TCM
IDYA icon

Tekla Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Tekla Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-133,185
Closed -$2.42M – 181
2022
Q4 		$2.42M Hold
133,185
– – 0.09% 106
2022
Q3 		$1.99M Buy
+133,185
New +$1.73M 0.08% 113
2022
Q1 		– Sell
-20,454
Closed -$484K – 176
2021
Q4 		$484K Buy
+20,454
New +$475K 0.02% 161

Other funds holding IDYA

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tekla Capital Management's IDYA Position: Q1 2023 in Review

Tekla Capital Management sold out of IDEAYA Biosciences (IDYA) in Q1 2023, closing a stake of 133,185 shares — an estimated $2.42M sold.

Tekla Capital Management first reported a position in IDYA in Q4 2021 and held it in 3 quarters. The position peaked at $2.42M in Q4 2022. 128 funds tracked by Wall St. Rank hold IDYA as of Q1 2023.

  • Tekla Capital Management reported no remaining IDEAYA Biosciences position as of Q1 2023 after selling out during the quarter.
  • Tekla Capital Management sold 133,185 IDEAYA Biosciences shares in Q1 2023, an estimated $2.42M.
  • Tekla Capital Management first reported a position in IDEAYA Biosciences in Q4 2021 and held it in 3 quarters.
  • Tekla Capital Management's IDEAYA Biosciences position peaked at $2.42M in Q4 2022.
  • 128 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2023.

Based on Tekla Capital Management's 13F filing for Q1 2023, filed 10 May 2023.